Trial intelligence / Profile preview

Probiotics and MSC Secretome for Acne Vulgaris

NCT06925386Phase 2Not yet recruiting

Sponsor
Universitas Padjadjaran
Start
May 2025
Primary completion
Dec 2025
Modality
Lipid-based Nanoparticles, Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of mesenchymal stem cell secretome in acne vulgaris, sponsored by Universitas Padjadjaran. Planned start May 2025; status: not yet recruiting.

02

Drugs

mesenchymal stem cell secretome
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT06925386.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06925386.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call